And despite their popularity, many Americans face barriers to accessing these treatments due to high costs and limited insurance coverage
However, the use of traditional anti-diabetic drugs, in most cases, does not significantly reduce macrovascular morbidity and mortality
Low ineffective doses may deliver no benefit while still costing money
Potential systemic anti-inflammatory effects could theoretically benefit multiple conditions characterized by chronic low-grade inflammation, including metabolic syndrome, cardiovascular disease, and certain autoimmune conditions
New from our team: a study of 330,000+ people in @BMJMedicine
Proton pump inhibitors (omeprazole, pantoprazole) offer the strongest suppression, reducing acid secretion by up to 90% over 24 hoursa useful option if dietary changes and antacids prove insufficient after 2-3 weeks of semaglutide use